What is the current Price Target for the Prokidney stock?

The average Prokidney target price is $4.50. This is 435.91% higher than the current stock price. The highest price target is 614.54%, the lowest is 257.27%. 4 Analysts have issued a price target Prokidney 2026 .

How high will the Prokidney stock rise?

No reliable answer can be given as to how high the Prokidney stock will rise. The performance of stocks, including the Prokidney stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Prokidney stock today?

The performance of Prokidney stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Prokidney stock fall?

The decline in Prokidney stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Prokidney Forecast, price target & analysts

$0.76

9.49% today

Nasdaq, Apr 03, 05:17 pm CET

ISIN

KYG7S53R1049

Symbol

PROK

Reports

Quarter | Annual

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Prokidney Target price 2025 - Analyst rating & recommendation

Prokidney Classifications & Recommendation:

Buy

40%

Hold

60%

Prokidney Price Target

Target Price	$4.50
Price	$0.84
Potential	435.91% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Prokidney 2026 . The average Prokidney target price is $4.50. This is 435.91% register free of charge higher than the current stock price. The highest price target is $6.00 614.54% register free of charge , the lowest is $3.00 257.27% register free of charge .
	A rating was issued by 5 analysts: 2 Analysts recommend Prokidney to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Prokidney stock has an average upside potential 2026 of 435.91% register free of charge . Most analysts recommend the Prokidney stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.62	-0.54
	8.77%	12.90%
P/E		negative

2 Analysts have issued a Prokidney forecast for earnings per share. The average Prokidney EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.62	8.77%
2025	$-0.54 12.90% Unlock
2026	$-0.51 5.56% Unlock
2027	$-0.82 60.78% Unlock

Current	-1.34	53.31%
2025	-1.55 15.67% Unlock
2026	-1.64 5.81% Unlock
2027	-1.02 37.80% Unlock

Prokidney...

Current Prokidney Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Sep 30 2024
Guggenheim	Locked ➜ Locked	Locked	Sep 10 2024
B of A Securities	Locked ➜ Locked	Locked	Sep 04 2024

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Sep 30 2024
Locked Guggenheim: Locked ➜ Locked	Sep 10 2024
Locked B of A Securities: Locked ➜ Locked	Sep 04 2024

Discover more stocks with a high price target

Novo Nordisk 71.46%

Coinbase Global, Inc. 71.30%

MongoDB 60.94%

TUI 60.13%

NVIDIA 57.75%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now